TY - JOUR AU - Wesseling, P. AU - Capper, D. PY - 2018 DA - 2018// TI - WHO 2016 classification of gliomas JO - Neuropathol Appl Neurobiol VL - 44 UR - https://doi.org/10.1111/nan.12432 DO - 10.1111/nan.12432 ID - Wesseling2018 ER - TY - JOUR AU - Batash, R. AU - Asna, N. AU - Schaffer, P. AU - Francis, N. AU - Schaffer, M. PY - 2017 DA - 2017// TI - Glioblastoma multiforme, diagnosis and treatment; recent literature review JO - Curr Med Chem. VL - 24 UR - https://doi.org/10.2174/0929867324666170516123206 DO - 10.2174/0929867324666170516123206 ID - Batash2017 ER - TY - JOUR AU - Stupp, R. AU - Hegi, M. E. AU - Mason, W. P. AU - Bent, M. J. AU - Taphoorn, M. J. B. AU - Janzer, R. C. PY - 2009 DA - 2009// TI - Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial JO - Lancet Oncol. VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70025-7 DO - 10.1016/S1470-2045(09)70025-7 ID - Stupp2009 ER - TY - JOUR AU - Touat, M. AU - Idbaih, A. AU - Sanson, M. AU - Ligon, K. L. PY - 2017 DA - 2017// TI - Glioblastoma targeted therapy: updated approaches from recent biological insights JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx106 DO - 10.1093/annonc/mdx106 ID - Touat2017 ER - TY - JOUR AU - Barth, R. F. AU - Zhang, Z. AU - Liu, T. PY - 2018 DA - 2018// TI - A realistic appraisal of boron neutron capture therapy as a cancer treatment modality JO - Cancer Commun (Lond). VL - 38 UR - https://doi.org/10.1186/s40880-018-0280-5 DO - 10.1186/s40880-018-0280-5 ID - Barth2018 ER - TY - JOUR AU - Sahara, K. AU - Kogleck, L. AU - Yashiroda, H. AU - Murata, S. PY - 2014 DA - 2014// TI - The mechanism for molecular assembly of the proteasome JO - Adv Biol Regul VL - 54 UR - https://doi.org/10.1016/j.jbior.2013.09.010 DO - 10.1016/j.jbior.2013.09.010 ID - Sahara2014 ER - TY - JOUR AU - Collins, G. A. AU - Goldberg, A. L. PY - 2017 DA - 2017// TI - The logic of the 26S proteasome JO - Cell VL - 169 UR - https://doi.org/10.1016/j.cell.2017.04.023 DO - 10.1016/j.cell.2017.04.023 ID - Collins2017 ER - TY - JOUR AU - Ding, F. B. AU - Xiao, H. B. AU - Wang, M. S. AU - Xie, X. AU - Hu, F. Q. PY - 2014 DA - 2014// TI - The role of the ubiquitin-proteasome pathway in cancer development and treatment JO - Front Biosci Landmrk VL - 19 UR - https://doi.org/10.2741/4254 DO - 10.2741/4254 ID - Ding2014 ER - TY - JOUR AU - Johnson, D. E. PY - 2015 DA - 2015// TI - The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors JO - Endocr Relat Cancer VL - 22 UR - https://doi.org/10.1530/ERC-14-0005 DO - 10.1530/ERC-14-0005 ID - Johnson2015 ER - TY - JOUR AU - Teicher, B. A. AU - Tomaszewski, J. E. PY - 2015 DA - 2015// TI - Proteasome inhibitors JO - Biochem Pharmacol VL - 96 UR - https://doi.org/10.1016/j.bcp.2015.04.008 DO - 10.1016/j.bcp.2015.04.008 ID - Teicher2015 ER - TY - JOUR AU - Gandolfi, S. AU - Laubach, J. P. AU - Hideshima, T. AU - Chauhan, D. AU - Anderson, K. C. AU - Richardson, P. G. PY - 2017 DA - 2017// TI - The proteasome and proteasome inhibitors in multiple myeloma JO - Cancer Metast Rev VL - 36 UR - https://doi.org/10.1007/s10555-017-9707-8 DO - 10.1007/s10555-017-9707-8 ID - Gandolfi2017 ER - TY - JOUR AU - Manasanch, E. E. AU - Orlowski, R. Z. PY - 2017 DA - 2017// TI - Proteasome inhibitors in cancer therapy JO - Nat Rev Clin Oncol VL - 14 UR - https://doi.org/10.1038/nrclinonc.2016.206 DO - 10.1038/nrclinonc.2016.206 ID - Manasanch2017 ER - TY - JOUR AU - Roeten, M. S. F. AU - Cloos, J. AU - Jansen, G. PY - 2018 DA - 2018// TI - Positioning of proteasome inhibitors in therapy of solid malignancies JO - Cancer Chemother Pharmacol VL - 81 UR - https://doi.org/10.1007/s00280-017-3489-0 DO - 10.1007/s00280-017-3489-0 ID - Roeten2018 ER - TY - JOUR AU - Bota, D. A. AU - Alexandru, D. AU - Keir, S. T. AU - Bigner, D. AU - Vredenburgh, J. AU - Friedman, H. S. PY - 2013 DA - 2013// TI - Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells’ VEGF production and angiogenesis JO - J Neurosurg VL - 119 UR - https://doi.org/10.3171/2013.7.JNS1323 DO - 10.3171/2013.7.JNS1323 ID - Bota2013 ER - TY - JOUR AU - Zaky, W. AU - Manton, C. AU - Miller, C. P. AU - Khatua, S. AU - Gopalakrishnan, V. AU - Chandra, J. PY - 2017 DA - 2017// TI - The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities JO - Cancer Metast Rev VL - 36 UR - https://doi.org/10.1007/s10555-017-9700-2 DO - 10.1007/s10555-017-9700-2 ID - Zaky2017 ER - TY - STD TI - The Cancer Genome Atlas (TCGA). The TCGA Research Network, National Cancer Institute at the National Institutes of Health. 2019. https://www.cancer.gov/tcga. Accessed 21 May 2019. UR - https://www.cancer.gov/tcga ID - ref16 ER - TY - STD TI - Beyotime. https://www.beyotime.com/product/C1062S.htm; https://www.beyotime.com/product/C1052.htm. Accessed 20 July 2018. UR - https://www.beyotime.com/product/C1052.htm ID - ref17 ER - TY - JOUR AU - McCracken, D. J. AU - Celano, E. C. AU - Voloschin, A. D. AU - Read, W. L. AU - Olson, J. J. PY - 2016 DA - 2016// TI - Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma JO - J Neuro-Oncol. VL - 130 UR - https://doi.org/10.1007/s11060-016-2234-6 DO - 10.1007/s11060-016-2234-6 ID - McCracken2016 ER - TY - JOUR AU - Raizer, J. J. AU - Chandler, J. P. AU - Ferrarese, R. AU - Grimm, S. A. AU - Levy, R. M. AU - Muro, K. PY - 2016 DA - 2016// TI - A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas JO - J Neuro-Oncol VL - 129 UR - https://doi.org/10.1007/s11060-016-2156-3 DO - 10.1007/s11060-016-2156-3 ID - Raizer2016 ER - TY - JOUR AU - Kong, X. T. AU - Nguyen, N. T. AU - Choi, Y. J. AU - Zhang, G. AU - Nguyen, H. N. AU - Filka, E. PY - 2018 DA - 2018// TI - Phase 2 study of bortezomib combined with temozolomide and regional radiation therapy for upfront treatment of patients with newly diagnosed glioblastoma multiforme: safety and efficacy assessment JO - Int J Radiat Oncol Biol Phys VL - 100 UR - https://doi.org/10.1016/j.ijrobp.2018.01.001 DO - 10.1016/j.ijrobp.2018.01.001 ID - Kong2018 ER - TY - JOUR AU - Yin, D. AU - Zhou, H. AU - Kumagai, T. AU - Liu, G. AU - Ong, J. M. AU - Black, K. L. PY - 2005 DA - 2005// TI - Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM) JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1208225 DO - 10.1038/sj.onc.1208225 ID - Yin2005 ER - TY - JOUR AU - Hattermann, K. AU - Fluh, C. AU - Engel, D. AU - Mehdorn, H. M. AU - Synowitz, M. AU - Mentlein, R. PY - 2016 DA - 2016// TI - Stem cell markers in glioma progression and recurrence JO - Int J Oncol VL - 49 UR - https://doi.org/10.3892/ijo.2016.3682 DO - 10.3892/ijo.2016.3682 ID - Hattermann2016 ER - TY - JOUR AU - Iwadate, Y. PY - 2018 DA - 2018// TI - Plasticity in glioma stem cell phenotype and its therapeutic implication JO - Neurol Med Chir (Tokyo). VL - 58 UR - https://doi.org/10.2176/nmc.ra.2017-0089 DO - 10.2176/nmc.ra.2017-0089 ID - Iwadate2018 ER - TY - JOUR AU - Yoo, Y. D. AU - Lee, D. H. AU - Cha-Molstad, H. AU - Kim, H. AU - Mun, S. R. AU - Ji, C. PY - 2017 DA - 2017// TI - Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition JO - EMBO Rep VL - 18 UR - https://doi.org/10.15252/embr.201744761 DO - 10.15252/embr.201744761 ID - Yoo2017 ER - TY - JOUR AU - Chamberlain, M. C. AU - Bota, D. A. AU - Linskey, M. E. AU - Schwartz, P. H. PY - 2011 DA - 2011// TI - Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy JO - Neurology VL - 77 UR - https://doi.org/10.1212/WNL.0b013e318239ba7c DO - 10.1212/WNL.0b013e318239ba7c ID - Chamberlain2011 ER - TY - JOUR AU - Vlachostergios, P. J. AU - Voutsadakis, I. A. AU - Papandreou, C. N. PY - 2013 DA - 2013// TI - Mechanisms of proteasome inhibitor-induced cytotoxicity in malignant glioma JO - Cell Biol Toxicol VL - 29 UR - https://doi.org/10.1007/s10565-013-9248-z DO - 10.1007/s10565-013-9248-z ID - Vlachostergios2013 ER - TY - JOUR AU - Qureshi, A. A. AU - Zuvanich, E. G. AU - Khan, D. A. AU - Mushtaq, S. AU - Silswal, N. AU - Qureshi, N. PY - 2018 DA - 2018// TI - Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin—proteasome pathways in cancer cell lines of different organs JO - Lipids Health Dis VL - 17 UR - https://doi.org/10.1186/s12944-018-0697-5 DO - 10.1186/s12944-018-0697-5 ID - Qureshi2018 ER - TY - JOUR AU - Concannon, C. G. AU - Koehler, B. F. AU - Reimertz, C. AU - Murphy, B. M. AU - Bonner, C. AU - Thurow, N. PY - 2007 DA - 2007// TI - Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1209974 DO - 10.1038/sj.onc.1209974 ID - Concannon2007 ER - TY - JOUR AU - Ding, W. X. AU - Ni, H. M. AU - Gao, W. AU - Yoshimori, T. AU - Stolz, D. B. AU - Ron, D. PY - 2007 DA - 2007// TI - Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability JO - Am J Pathol VL - 171 UR - https://doi.org/10.2353/ajpath.2007.070188 DO - 10.2353/ajpath.2007.070188 ID - Ding2007 ER - TY - JOUR AU - Halasi, M. AU - Gartel, A. L. PY - 2013 DA - 2013// TI - FOX(M1) news—it is cancer JO - Mol Cancer Therap. VL - 12 UR - https://doi.org/10.1158/1535-7163.MCT-12-0712 DO - 10.1158/1535-7163.MCT-12-0712 ID - Halasi2013 ER - TY - JOUR AU - Radhakrishnan, S. K. AU - Bhat, U. G. AU - Hughes, D. E. AU - Wang, I. C. AU - Costa, R. H. AU - Gartel, A. L. PY - 2006 DA - 2006// TI - Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1 JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-1576 DO - 10.1158/0008-5472.CAN-06-1576 ID - Radhakrishnan2006 ER - TY - JOUR AU - Bhat, U. G. AU - Halasi, M. AU - Gartel, A. L. PY - 2009 DA - 2009// TI - Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells JO - PLoS ONE VL - 4 UR - https://doi.org/10.1371/journal.pone.0005592 DO - 10.1371/journal.pone.0005592 ID - Bhat2009 ER - TY - JOUR AU - Bhat, U. G. AU - Halasi, M. AU - Gartel, A. L. PY - 2009 DA - 2009// TI - FoxM1 is a general target for proteasome inhibitors JO - PLoS ONE VL - 4 UR - https://doi.org/10.1371/journal.pone.0006593 DO - 10.1371/journal.pone.0006593 ID - Bhat2009 ER - TY - JOUR AU - Halasi, M. AU - Gartel, A. L. PY - 2009 DA - 2009// TI - A novel mode of FoxM1 regulation: positive auto-regulatory loop JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.12.8708 DO - 10.4161/cc.8.12.8708 ID - Halasi2009 ER - TY - JOUR AU - Nestal de Moraes, G. AU - Delbue, D. AU - Silva, K. L. AU - Robaina, M. C. AU - Khongkow, P. AU - Gomes, A. R. PY - 2015 DA - 2015// TI - FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance JO - Cell Signal VL - 27 UR - https://doi.org/10.1016/j.cellsig.2015.09.013 DO - 10.1016/j.cellsig.2015.09.013 ID - Nestal de Moraes2015 ER - TY - JOUR AU - Nunes, A. T. AU - Annunziata, C. M. PY - 2017 DA - 2017// TI - Proteasome inhibitors: structure and function JO - Semin Oncol VL - 44 UR - https://doi.org/10.1053/j.seminoncol.2018.01.004 DO - 10.1053/j.seminoncol.2018.01.004 ID - Nunes2017 ER - TY - JOUR AU - Liao, G. B. AU - Li, X. Z. AU - Zeng, S. AU - Liu, C. AU - Yang, S. M. AU - Yang, L. PY - 2018 DA - 2018// TI - Regulation of the master regulator FOXM1 in cancer JO - Cell Commun Signal. VL - 16 UR - https://doi.org/10.1186/s12964-018-0266-6 DO - 10.1186/s12964-018-0266-6 ID - Liao2018 ER - TY - JOUR AU - Gartel, A. L. PY - 2013 DA - 2013// TI - Thiazole antibiotics siomycin a and thiostrepton inhibit the transcriptional activity of FOXM1 JO - Front Oncol VL - 3 UR - https://doi.org/10.3389/fonc.2013.00150 DO - 10.3389/fonc.2013.00150 ID - Gartel2013 ER - TY - JOUR AU - Halasi, M. AU - Váraljai, R. AU - Benevolenskaya, E. AU - Gartel, A. L. PY - 2016 DA - 2016// TI - A novel function of molecular chaperone HSP70: suppression of oncogenic FOXM1 after proteotoxic stresS JO - J Biol Chem VL - 291 UR - https://doi.org/10.1074/jbc.M115.678227 DO - 10.1074/jbc.M115.678227 ID - Halasi2016 ER - TY - JOUR AU - Cheng, X. H. AU - Black, M. AU - Ustiyan, V. AU - Le, T. AU - Fulford, L. AU - Sridharan, A. PY - 2014 DA - 2014// TI - SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene JO - PLoS Genet VL - 10 UR - https://doi.org/10.1371/journal.pgen.1004656 DO - 10.1371/journal.pgen.1004656 ID - Cheng2014 ER - TY - JOUR AU - Larrue, C. AU - Saland, E. AU - Boutzen, H. AU - Vergez, F. AU - David, M. AU - Joffre, C. PY - 2016 DA - 2016// TI - Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2015-05-646497 DO - 10.1182/blood-2015-05-646497 ID - Larrue2016 ER - TY - JOUR AU - Li, X. AU - Liang, M. AU - Jiang, J. AU - He, R. AU - Wang, M. AU - Guo, X. PY - 2018 DA - 2018// TI - Combined inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production and ER stress in pancreatic cancer cells JO - Int J Biol Sci. VL - 14 UR - https://doi.org/10.7150/ijbs.26776 DO - 10.7150/ijbs.26776 ID - Li2018 ER - TY - JOUR AU - Zhang, Y. AU - Bai, C. AU - Lu, D. AU - Wu, X. AU - Gao, L. AU - Zhang, W. PY - 2016 DA - 2016// TI - Endoplasmic reticulum stress and autophagy participate in apoptosis induced by bortezomib in cervical cancer cells JO - Biotechnol Lett VL - 38 UR - https://doi.org/10.1007/s10529-015-1968-0 DO - 10.1007/s10529-015-1968-0 ID - Zhang2016 ER - TY - JOUR AU - Zhang, X. AU - Li, W. AU - Wang, C. AU - Leng, X. AU - Lian, S. AU - Feng, J. PY - 2014 DA - 2014// TI - Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells JO - Mol Cell Biochem VL - 385 UR - https://doi.org/10.1007/s11010-013-1835-z DO - 10.1007/s11010-013-1835-z ID - Zhang2014 ER - TY - JOUR AU - Dong, G. Z. AU - Jeong, J. H. AU - Lee, Y. I. AU - Han, Y. E. AU - Shin, J. S. AU - Kim, Y. J. PY - 2017 DA - 2017// TI - A lignan induces lysosomal dependent degradation of FoxM1 protein to suppress β-catenin nuclear translocation JO - Sci Rep. VL - 7 UR - https://doi.org/10.1038/srep45951 DO - 10.1038/srep45951 ID - Dong2017 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Lee, Y. AU - Kim, K. H. AU - Kim, D. G. AU - Cho, H. J. AU - Kim, Y. AU - Rheey, J. PY - 2015 DA - 2015// TI - FoxM1 promotes stemness and radio-resistance of glioblastoma by regulating the master stem cell regulator Sox2 JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0137703 DO - 10.1371/journal.pone.0137703 ID - Lee2015 ER - TY - JOUR AU - Gong, A. H. AU - Wei, P. AU - Zhang, S. AU - Yao, J. AU - Yuan, Y. AU - Zhou, A. D. PY - 2015 DA - 2015// TI - FoxM1 drives a feed-forward STAT3-activation signaling loop that promotes the self-renewal and tumorigenicity of glioblastoma stem-like cells JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-2800 DO - 10.1158/0008-5472.CAN-14-2800 ID - Gong2015 ER - TY - JOUR AU - Kim, S. H. AU - Joshi, K. AU - Ezhilarasan, R. AU - Myers, T. R. AU - Siu, J. AU - Gu, C. PY - 2015 DA - 2015// TI - EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner JO - Stem Cell Reports. VL - 4 UR - https://doi.org/10.1016/j.stemcr.2014.12.006 DO - 10.1016/j.stemcr.2014.12.006 ID - Kim2015 ER - TY - JOUR AU - Zhang, N. AU - Wu, X. AU - Yang, L. AU - Xiao, F. AU - Zhang, H. AU - Zhou, A. PY - 2012 DA - 2012// TI - FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51 JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0039 DO - 10.1158/1078-0432.CCR-12-0039 ID - Zhang2012 ER - TY - JOUR AU - Peng, W. X. AU - Han, X. AU - Zhang, C. L. AU - Ge, L. AU - Du, F. Y. AU - Jin, J. PY - 2017 DA - 2017// TI - FoxM1-mediated RFC5 expression promotes temozolomide resistance JO - Cell Biol Toxicol VL - 33 UR - https://doi.org/10.1007/s10565-017-9381-1 DO - 10.1007/s10565-017-9381-1 ID - Peng2017 ER - TY - JOUR AU - Sun, X. P. AU - Dong, X. AU - Lin, L. AU - Jiang, X. AU - Wei, Z. AU - Zhai, B. PY - 2014 DA - 2014// TI - Up-regulation of survivin by AKT and hypoxia-inducible factor 1a contributes to cisplatin resistance in gastric cancer JO - FEBS J VL - 281 UR - https://doi.org/10.1111/febs.12577 DO - 10.1111/febs.12577 ID - Sun2014 ER - TY - JOUR AU - Zhang, S. AU - Zhang, C. AU - Song, Y. AU - Zhang, J. AU - Xu, J. PY - 2018 DA - 2018// TI - Prognostic role of survivin in patients with glioma JO - Medicine (Baltimore). VL - 97 UR - https://doi.org/10.1097/MD.0000000000010571 DO - 10.1097/MD.0000000000010571 ID - Zhang2018 ER - TY - JOUR AU - Jane, E. P. AU - Premkumar, D. R. AU - Sutera, P. A. AU - Cavaleri, J. M. AU - Pollack, I. F. AU - Esther, P. PY - 2017 DA - 2017// TI - Pollack survivin inhibitor YM155 induces mitochondrial dysfunction, autophagy, DNA damage, and apoptosis in Bcl-xL silenced glioma cell lines JO - Mol Carcinogen VL - 56 UR - https://doi.org/10.1002/mc.22587 DO - 10.1002/mc.22587 ID - Jane2017 ER - TY - JOUR AU - Wang, W. AU - Cho, H. Y. AU - Rosenstein-Sisson, R. AU - Marín Ramos, N. I. AU - Price, R. AU - Hurth, K. PY - 2018 DA - 2018// TI - Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model JO - J Neurosurg VL - 128 UR - https://doi.org/10.3171/2016.11.JNS161212 DO - 10.3171/2016.11.JNS161212 ID - Wang2018 ER - TY - JOUR AU - Liu, Y. X. AU - Liu, W. J. AU - Zhang, H. R. AU - Zhang, Z. W. PY - 2018 DA - 2018// TI - Delivery of bevacizumab by intracranial injection: assessment in glioma model JO - Oncol Targets Ther. VL - 11 UR - https://doi.org/10.2147/OTT.S159913 DO - 10.2147/OTT.S159913 ID - Liu2018 ER - TY - JOUR AU - Park, J. E. AU - Miller, Z. AU - Jun, Y. AU - Lee, W. AU - Kim, K. B. PY - 2018 DA - 2018// TI - Next-generation proteasome inhibitors for cancer therapy JO - Transl Res. VL - 198 UR - https://doi.org/10.1016/j.trsl.2018.03.002 DO - 10.1016/j.trsl.2018.03.002 ID - Park2018 ER - TY - JOUR AU - Carmony, K. AU - Lee, W. AU - Kim, K. B. PY - 2016 DA - 2016// TI - High-resolution snapshots of proteasome inhibitors in action revise inhibition paradigms and inspire next-generation inhibitor design JO - ChemBioChem VL - 17 UR - https://doi.org/10.1002/cbic.201600488 DO - 10.1002/cbic.201600488 ID - Carmony2016 ER -